Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123349
Filing Date
2024-11-07
Accepted
2024-11-07 16:13:33
Documents
60
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dsgn-20240930.htm   iXBRL 10-Q 2079978
2 EX-31.1 dsgn-ex31_1.htm EX-31.1 17546
3 EX-32.1 dsgn-ex32_1.htm EX-32.1 11505
  Complete submission text file 0000950170-24-123349.txt   7429292

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dsgn-20240930.xsd EX-101.SCH 803147
62 EXTRACTED XBRL INSTANCE DOCUMENT dsgn-20240930_htm.xml XML 1430047
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40288 | Film No.: 241435865
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)